Elanco Animal Health (ELAN) Enterprise Value (2017 - 2026)
Elanco Animal Health (ELAN) reported Enterprise Value of -$428.0 million for Q1 2026, up 12.11% on a YoY basis from -$381.8 million in Q1 2025, and up 21.47% sequentially from -$545.0 million in Q4 2025.
Elanco Animal Health (ELAN) Enterprise Value (2017 - 2026) Analysis & Trends
Elanco Animal Health (ELAN) has 10 years of Enterprise Value data on file, last reported at -$428.0 million in Q1 2026.
- For the quarter ending Q1 2026, Enterprise Value rose 12.11% year-over-year to -$428.0 million; the trailing twelve-month figure through Mar 2026 stood at -$428.0 million (up 12.11% YoY), and the FY2025 full-year result was -$545.0 million, down 16.45% from the prior year.
- Enterprise Value grew to -$428.0 million in Q1 2026, from -$545.0 million in the prior quarter.
- In the past five years, Enterprise Value ranged from a high of -$318.0 million in Q1 2023 to a low of -$545.0 million in Q4 2025.
- A 5-year average of -$428.4 million and a median of -$428.0 million in 2026 frame the typical range for Enterprise Value.
- Across the five-year window, Enterprise Value jumped 45.92% in 2022 and tumbled 41.16% in 2025, its largest moves.
- Tracing ELAN's Enterprise Value over 5 years: stood at -$345.0 million in 2022, then retreated by 2.03% to -$352.0 million in 2023, then tumbled by 32.95% to -$468.0 million in 2024, then fell by 16.45% to -$545.0 million in 2025, then advanced by 21.47% to -$428.0 million in 2026.
- Business Quant data shows ELAN's Enterprise Value at -$428.0 million in Q1 2026, -$545.0 million in Q4 2025, and -$505.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 88.07 Bn | 86.20 Bn | - | -1.86 Bn |
| 2 | Teva Pharmaceutical Industries | 35.75 Bn | 32.01 Bn | 1.97 Bn | -3.74 Bn |
| 3 | Zoetis | 31.84 Bn | 29.90 Bn | 1.62 Bn | -1.94 Bn |
| 4 | Takeda Pharmaceutical | 27.18 Bn | 23.12 Bn | 4.39 Bn | -4.05 Bn |
| 5 | United Therapeutics | 23.09 Bn | 20.93 Bn | 648.10 Mn | -2.15 Bn |
| 6 | RedHill Biopharma | 21.32 Bn | 21.32 Bn | - | -3.97 Mn |
| 7 | Viatris | 19.96 Bn | 18.16 Bn | 1.16 Bn | -1.80 Bn |
| 8 | Neurocrine Biosciences | 17.66 Bn | 16.34 Bn | 800.70 Mn | -1.32 Bn |
| 9 | Elanco Animal Health | 12.44 Bn | 12.02 Bn | 785.00 Mn | -428.00 Mn |
| 10 | Vireo Growth | 10.53 Bn | 10.38 Bn | 59.30 Mn | -153.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -428.00 Mn |
| Dec 31, 2025 | -545.00 Mn |
| Sep 30, 2025 | -505.00 Mn |
| Jun 30, 2025 | -539.00 Mn |
| Mar 31, 2025 | -487.00 Mn |
| Dec 31, 2024 | -468.00 Mn |
| Sep 30, 2024 | -490.00 Mn |
| Jun 30, 2024 | -416.00 Mn |
| Mar 31, 2024 | -345.00 Mn |
| Dec 31, 2023 | -352.00 Mn |
| Sep 30, 2023 | -369.00 Mn |
| Jun 30, 2023 | -367.00 Mn |
| Mar 31, 2023 | -318.00 Mn |
| Dec 31, 2022 | -345.00 Mn |
| Sep 30, 2022 | -460.00 Mn |
| Jun 30, 2022 | -507.00 Mn |
| Mar 31, 2022 | -342.00 Mn |
| Dec 31, 2021 | -638.00 Mn |
| Sep 30, 2021 | -453.00 Mn |
| Jun 30, 2021 | -580.00 Mn |